Cholinesterases in the Cerebrospinal Fluid, Plasma, and Erythrocytes of Patients with Alzheimer's Disease

Overview

Journal J Neural Transm

Specialties Neurology
Physiology

Date 1989 Jan 1

PMID 2918304

Citations 4

Authors

J Sirvio

R Kutvonen

H Soininen

P Hartikainen

P J Riekkinen

Affiliations

Soon will be listed here.

Abstract

In patients with probable Alzheimer's disease and in controls, acetyl- and butyrylcholinesterase activities were studied in cerebrospinal fluid (CSF) and plasma, and acetylcholinesterase activity of erythrocytes was determined. In addition, the molecular forms of acetylcholinesterase were measured in CSF. Severely demented patients had significantly lower acetylcholinesterase (p less than 0.01) and butyrylcholinesterase (p less than 0.05) activities in CSF than the controls had, but the activities of these enzymes in plasma and erythrocytes were within the same range in both groups. Acetylcholinesterase and butyrylcholinesterase activities in the CSF of mildly demented patients did not differ from control values. The ratio of the intermediate molecular form of acetylcholinesterase to the light molecular form of the enzyme did not differ significantly between patients with Alzheimer's disease and controls. According to our results, AChE levels were lower in the CSF of severely demented patients, but both light and intermediate molecular forms were affected.

Citing Articles

Salivary biomarkers for the diagnosis and monitoring of neurological diseases.

Farah R, Haraty H, Salame Z, Fares Y, Ojcius D, Sadier N Biomed J. 2018; 41(2):63-87.

PMID: 29866603 PMC: 6138769. DOI: 10.1016/j.bj.2018.03.004.

Reassessing blood acetylcholinesterase in dementia.

Han P J Neurosci Rural Pract. 2015; 6(1):6-7.

PMID: 25552843 PMC: 4244791. DOI: 10.4103/0976-3147.143167.

Altered levels of acetylcholinesterase in Alzheimer plasma.

Garcia-Ayllon M, Riba-Llena I, Serra-Basante C, Alom J, Boopathy R, Saez-Valero J PLoS One. 2010; 5(1):e8701.

PMID: 20090844 PMC: 2806824. DOI: 10.1371/journal.pone.0008701.

Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Hartikainen P, Soininen H, Reinikainen K, Sirvio J, Soikkeli R, Riekkinen P J Neural Transm Gen Sect. 1991; 84(1-2):103-17.

PMID: 1675857 DOI: 10.1007/BF01249114.

References

Festoff B, Fernandez H . Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis. Muscle Nerve. 1981; 4(1):41-7. DOI: 10.1002/mus.880040108. View

Atack J, Perry E, Bonham J, Candy J, Perry R . Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem. 1986; 47(1):263-77. DOI: 10.1111/j.1471-4159.1986.tb02858.x. View

Lal S, Wood P, Kiely M, Etienne P, Gauthier S, Stratford J . CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging. 1984; 5(4):269-74. DOI: 10.1016/0197-4580(84)90002-2. View

Bareggi S, Giacobini E . Acetylcholinesterase activity in ventricular and cisternal CSF of dogs: effect of chlorpromazine. J Neurosci Res. 1978; 3(5-6):335-9. DOI: 10.1002/jnr.490030504. View

Elble R, Giacobini E, Scarsella G . Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease. Arch Neurol. 1987; 44(4):403-7. DOI: 10.1001/archneur.1987.00520160041012. View

Whitehouse P, Struble R, Hedreen J, CLARK A, Price D . Alzheimer's disease and related dementias: selective involvement of specific neuronal systems. CRC Crit Rev Clin Neurobiol. 1985; 1(4):319-39. View

Riekkinen P, Soininen H, Sirvio J, Reinikainen K, Helkala E, Paljarvi L . Dementia without cholinergic deficit. Gerontology. 1987; 33(3-4):268-72. DOI: 10.1159/000212889. View

Sims N, Bowen D, Allen S, Smith C, Neary D, Thomas D . Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem. 1983; 40(2):503-9. DOI: 10.1111/j.1471-4159.1983.tb11311.x. View

Bisso G, Masullo C, Michalek H, Silveri M, Pocchiari M . Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls. Life Sci. 1986; 38(6):561-7. DOI: 10.1016/0024-3205(86)90035-4. View

10.

Sirvio J, Soininen H, Kutvonen R, Hyttinen J, Helkala E, Riekkinen P . Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease. J Neurol Sci. 1987; 81(2-3):273-9. DOI: 10.1016/0022-510x(87)90102-x. View

11.

Brimijoin S . Molecular forms of acetylcholinesterase in brain, nerve and muscle: nature, localization and dynamics. Prog Neurobiol. 1983; 21(4):291-322. DOI: 10.1016/0301-0082(83)90015-1. View

12.

Arendt T, Bigl V, Walther F, Sonntag M . Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease. Lancet. 1984; 1(8369):173. DOI: 10.1016/s0140-6736(84)90116-8. View

13.

TUNE L, Gucker S, Folstein M, Oshida L, Coyle J . Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Ann Neurol. 1985; 17(1):46-8. DOI: 10.1002/ana.410170111. View

14.

Katzman R . Alzheimer's disease. N Engl J Med. 1986; 314(15):964-73. DOI: 10.1056/NEJM198604103141506. View

15.

Nakano S, Kato T, Nakamura S, Kameyama M . Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. J Neurol Sci. 1986; 75(2):213-23. DOI: 10.1016/0022-510x(86)90096-1. View

16.

Fishman E, Siek G, MacCallum R, BIRD E, Volicer L, Marquis J . Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type. Ann Neurol. 1986; 19(3):246-52. DOI: 10.1002/ana.410190305. View

17.

Hughes C, Berg L, Danziger W, COBEN L, Martin R . A new clinical scale for the staging of dementia. Br J Psychiatry. 1982; 140:566-72. DOI: 10.1192/bjp.140.6.566. View

18.

Soininen H, Jolkkonen J, Reinikainen K, Halonen T, Riekkinen P . Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Sci. 1984; 63(2):167-72. DOI: 10.1016/0022-510x(84)90193-x. View

19.

Hollander E, Mohs R, Davis K . Antemortem markers of Alzheimer's disease. Neurobiol Aging. 1986; 7(5):367-407. DOI: 10.1016/0197-4580(86)90164-8. View

20.

Marquis J, Volicer L, Mark K, Direnfeld L, Freedman M . Cholinesterase activity in plasma, erythrocytes, and cerebrospinal fluid of patients with dementia of the Alzheimer type. Biol Psychiatry. 1985; 20(6):605-10. DOI: 10.1016/0006-3223(85)90095-2. View